# Dexmedetomidine-ketamine Versus Propofol-ketamine for Sedation During Endoscopy in Hepatic Patients

> **NCT04906772** · PHASE4 · COMPLETED · sponsor: **Tamer Nabil Abdelrahman** · enrollment: 70 (actual)

## Conditions studied

- Anesthesia; Reaction

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT04906772
- **Lead sponsor:** Tamer Nabil Abdelrahman
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-03
- **Primary completion:** 2021-07-13
- **Final completion:** 2021-09-30
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2024-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04906772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04906772, "Dexmedetomidine-ketamine Versus Propofol-ketamine for Sedation During Endoscopy in Hepatic Patients". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04906772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*